Cytopag Tablet contains Eltrombopag Olamine 25 mg, a thrombopoietin receptor agonist used to increase platelet production in patients with low platelet counts. It is primarily indicated for conditions like chronic immune thrombocytopenia (ITP), thrombocytopenia associated with chronic hepatitis C, and severe aplastic anemia. By stimulating the thrombopoietin receptor in bone marrow, Eltrombopag promotes the proliferation and differentiation of megakaryocytes, which in turn increases platelet production. Cytopag helps reduce the risk of bleeding and improves quality of life in patients with low platelet levels.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Indications
Cytopag Tablet 25 mg is indicated for:
-
Treatment of chronic immune thrombocytopenia (ITP) in adults and children who are unresponsive to standard therapy
-
Management of thrombocytopenia associated with chronic hepatitis C to enable initiation or maintenance of interferon-based therapy
-
Adjunctive treatment in severe aplastic anemia for patients not responding adequately to immunosuppressive therapy
Mechanism of Action
-
Eltrombopag Olamine: Acts as a thrombopoietin receptor agonist by binding to the transmembrane domain of the receptor on megakaryocytes.
-
Effect: Stimulates the proliferation and differentiation of megakaryocytes in bone marrow, increasing platelet production in the bloodstream.
-
Helps reduce the risk of bleeding and supports safer management of hematologic conditions associated with low platelet counts.
Dosage and Administration
-
Adults with ITP: Typically 25 mg once daily; dose may be adjusted based on platelet response
-
Children with ITP: Dosing should be individualized according to body weight and response
-
Take the tablet on an empty stomach or at least 2 hours before or 4 hours after meals, especially avoiding calcium-rich foods or supplements that may interfere with absorption
-
Regular monitoring of platelet counts, liver function tests, and complete blood counts is recommended
-
Do not exceed the prescribed dose
Benefits
-
Increases platelet counts effectively in patients with thrombocytopenia
-
Reduces the risk of spontaneous or treatment-related bleeding
-
Supports continuation of therapies that may otherwise be halted due to low platelets
-
Improves overall patient safety and quality of life
-
Oral administration allows convenient daily dosing
Side Effects
Common side effects may include:
-
Headache
-
Nausea or vomiting
-
Fatigue or dizziness
-
Mild liver enzyme elevation
Serious but rare side effects:
-
Severe liver toxicity
-
Thromboembolic events (blood clots)
-
Cataracts or eye-related changes
-
Allergic reactions
Regular monitoring by a physician is essential to minimize risks.
Precautions
-
Monitor liver function tests regularly
-
Avoid sudden discontinuation without medical advice
-
Use with caution in patients with a history of thromboembolism
-
Inform your physician about all medications and supplements, particularly those containing calcium or polyvalent cations
-
Not recommended during pregnancy or breastfeeding unless advised by a physician
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Use in Special Populations
-
Pregnancy and Lactation: Only under strict medical supervision
-
Elderly: Monitor for liver function and potential thrombotic complications
-
Renal impairment: Dose adjustment may be necessary
Storage
-
Store below 30°C in a dry place
-
Protect from moisture and light
-
Keep out of reach of children.